Dawn Elaine Smilek (Dawn E Smilek)

Years Active: 2017-2020
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Yemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, Margie Byron, Linna Ding, Sai Kanaparthi, William T Barry, Wendy Gao, Kristin Ryker, Patti Tosta, Anca D Askanase, Susan A Boackle, W Winn Chatham, Diane L Kamen, Edward M Behrens, Kyriakos A Kirou, Sung Sam Lim, Bradley Marder, Maureen McMahon, Samir V Parikh, William F Pendergraft, Amber S Podoll, Amit Saxena, David Wofsy, Betty Diamond, Dawn Elaine Smilek, Cynthia Aranow, Maria Dall'Era
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis. Arthritis & rheumatology (Hoboken, N.J.) 73 (1) (2020)
Dawn Elaine Smilek, Noha Lim, Linna Ding, Sara G Murray, Betty Diamond, David Wofsy
Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis. Lupus science & medicine 4 (1) (2017)

Dawn Elaine Smilek.css-eqlu8i{font-size:small;padding-left:4px;} (Dawn E Smilek)